Prescription drug abuse has risen over the past two decades due to a combination of factors: widespread overprescribing, economic despair, gaps in mental health care, the flood of counterfeit pills laced with fentanyl, and an insurance system that often makes addictive medications easier to access than safer alternatives. About 14.3 million Americans aged 12 or older misused a prescription drug in 2021, with pain relievers accounting for the largest share at 8.7 million people.
Overprescribing Set the Foundation
The roots of the current crisis trace back to the 1990s, when a global shift in how doctors thought about pain led to a dramatic increase in opioid prescribing, particularly in the Americas, Europe, and Oceania. Pharmaceutical companies aggressively marketed opioid painkillers as safe for long-term use, and doctors began writing prescriptions for conditions that previously would have been managed with over-the-counter medications or physical therapy. The United States became one of the top consumers of controlled opioids worldwide, using roughly 398 milligrams per person. Germany and Iceland have since surpassed the U.S. in per-person consumption, but America’s decades-long prescribing boom left millions of people physically dependent on medications they were told were safe.
That flood of prescriptions created a massive supply of pills sitting in medicine cabinets across the country. Many people who misuse prescription drugs get them from friends, family members, or leftover prescriptions rather than buying them on the street. The sheer volume of pills in circulation made diversion almost inevitable.
Economic Despair and Social Isolation
Prescription drug misuse doesn’t happen in a vacuum. Research published in the American Journal of Public Health describes the opioid crisis as fundamentally fueled by economic and social upheaval, with opioids serving as “a refuge from physical and psychological trauma, concentrated disadvantage, isolation, and hopelessness.” In regions like the Midwest, Appalachia, and New England, mortality rates from what researchers call “diseases of despair” climb as county-level economic distress worsens.
This pattern makes sense when you consider what drives people to misuse these drugs. When jobs disappear, communities hollow out, and affordable mental health care is hard to find, prescription medications become a way to manage emotional pain alongside physical pain. The intersection of social disadvantage, isolation, and chronic pain creates conditions that high-volume primary care visits, often lasting 15 minutes or less, simply cannot address in a meaningful way.
Insurance Gaps Push People Toward Pills
Clinical guidelines recommend treatments like physical therapy, acupuncture, cognitive behavioral therapy, chiropractic care, and massage for managing chronic pain. But insurance coverage for these options is inconsistent across both private and public plans, including Medicare and Medicaid. Only seven states have introduced legislation specifically aimed at improving access to non-drug pain treatments.
The practical result: a patient with chronic back pain can often get a prescription for opioids covered with a small copay, but faces hundreds of dollars out of pocket for a course of physical therapy or acupuncture sessions. When the cheaper, more accessible option is the one with addiction potential, misuse becomes a predictable outcome rather than a surprising one. Colorado’s legislation, for example, had to specifically address the fact that some insurers were requiring patients to try non-drug therapies before covering opioids, while simultaneously not covering enough of those therapy visits to make them viable.
Counterfeit Pills and Fentanyl
One of the most dangerous recent developments is the explosion of counterfeit prescription pills. These are pills manufactured illegally to look identical to common medications like oxycodone or Xanax but laced with illicitly produced fentanyl. The DEA has found that six out of ten fentanyl-laced counterfeit pills now contain a potentially lethal dose, up from four out of ten in 2021.
The scale is staggering. The DEA seized more than 20.4 million fake prescription pills in 2021 alone, and in a single three-month enforcement operation, agents seized another 10.2 million pills across all 50 states. These counterfeits blur the line between prescription drug abuse and illicit drug use. Someone who believes they are taking a pharmaceutical-grade painkiller or anti-anxiety medication may actually be ingesting a dose of fentanyl potent enough to kill them. This has made what was already a dangerous pattern of misuse significantly more lethal.
Stimulant Misuse and the Pressure to Perform
Prescription drug abuse isn’t limited to painkillers. Stimulant medications prescribed for ADHD are widely misused, particularly among college students and young adults. About 8 percent of U.S. undergraduates reported misusing prescription stimulants at least once in 2017, with rates at individual universities ranging from 8 to nearly 20 percent.
The reasons people give for misusing stimulants reveal what’s driving this trend. Among adults who misused stimulants in 2022, about a third did so to help concentrate, 28 percent to stay awake or alert, and 12 percent specifically to help study. Among university students who misused stimulants for academic purposes, 70 percent did so during finals or exams, 51 percent before a test or project, and 47 percent when they felt behind in their coursework. Only 5 percent cited needing a competitive edge. This is less about getting high and more about coping with academic and professional pressure in environments that reward constant productivity.
There is some encouraging news on this front. Adult stimulant misuse among 19- to 30-year-olds dropped from 7.8 percent in 2022 to 3.7 percent in 2023. The broader trend among 18- to 25-year-olds shows a similar decline, from 7.5 percent in 2016 to 3.1 percent in 2023. Still, an estimated 3.9 million Americans misused prescription stimulants in 2023.
Telemedicine Expanded Access for Better and Worse
The COVID-19 pandemic led to a rapid expansion of telemedicine, including the ability to prescribe controlled substances through video calls without requiring an in-person visit first. Under current rules, DEA-registered practitioners can remotely prescribe Schedule II through V controlled medications, which includes powerful opioids, stimulants, and benzodiazepines, through audio-video telemedicine encounters without ever seeing the patient in person.
These flexibilities were designed for good reasons: ensuring patients in rural areas, elderly individuals, and people with mobility limitations can access necessary medications. But the same ease of access that benefits legitimate patients also creates opportunities for diversion. The DEA has repeatedly extended these telemedicine flexibilities while working to finalize permanent regulations. As DEA officials have acknowledged, the challenge is balancing patient access with safeguards against pills ending up in the wrong hands.
Young People Face Unique Risks
About 5 percent of high school seniors reported misusing at least one prescription drug in 2022. The patterns vary by drug type. Stimulant misuse is highest among younger teens, with 3.2 percent of 8th graders misusing amphetamines compared to 2.9 percent of 12th graders. Opioid and sedative misuse trends in the opposite direction, increasing with age: 1.9 percent of 12th graders reported misusing OxyContin compared to 0.7 percent of 8th graders.
For young people, the path to misuse often starts with medications that are already in their household or that friends have access to through legitimate prescriptions. The normalization of prescription drugs as everyday tools for managing pain, anxiety, or focus lowers the perceived risk. A pill from a pharmacy feels inherently safer than a street drug, even when the pharmacological risks are comparable.
Why the Problem Persists
Prescription drug abuse stays elevated because its causes reinforce each other. Economic hardship increases physical and emotional pain. Limited insurance coverage channels that pain toward prescription medications. Leftover pills and telemedicine access make those medications easy to obtain. Counterfeit pills introduce lethal fentanyl into what people believe is a controlled pharmaceutical supply. And the social stigma around addiction keeps many people from seeking treatment until they’re in crisis.
Addressing any single factor in isolation, whether through prescribing limits, expanded insurance coverage for alternative therapies, or crackdowns on counterfeit pills, only touches one piece of a problem woven deeply into how Americans manage pain, stress, and economic hardship. The rise in prescription drug abuse reflects not just a failure of drug policy but a broader set of conditions that make these medications feel like the most accessible solution to problems that are, at their core, social and economic.